🇺🇸 FDA
Patent

US 7442543

Mammalian selenoprotein differentially expressed in tumor cells

granted A61KA61K38/00

Quick answer

US patent 7442543 (Mammalian selenoprotein differentially expressed in tumor cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00